Zsigmond Kósa1, Ágota Moravcsik-Kornyicki2, Judit Diószegi3, Bayard Roberts4, Zoltán Szabó5, János Sándor6, Róza Ádány7. 1. 1 Department of Methodology for Health Visitors and Public Health, Faculty of Health, University of Debrecen, Nyíregyháza, Hungary. 2. 2 Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary 3 MTA-DE Public Health Research Group of the Hungarian Academy of Sciences, University of Debrecen, Debrecen, Hungary 4 Department of Preventive Medicine, WHO Collaborating Centre on Vulnerability and Health, University of Debrecen, Debrecen, Hungary. 3. 2 Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary 3 MTA-DE Public Health Research Group of the Hungarian Academy of Sciences, University of Debrecen, Debrecen, Hungary. 4. 5 Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK. 5. 6 Institute of Internal Medicine, University of Debrecen, Debrecen, Hungary. 6. 2 Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. 7. 2 Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary 3 MTA-DE Public Health Research Group of the Hungarian Academy of Sciences, University of Debrecen, Debrecen, Hungary 4 Department of Preventive Medicine, WHO Collaborating Centre on Vulnerability and Health, University of Debrecen, Debrecen, Hungary adany.roza@sph.unideb.hu.
Abstract
OBJECTIVES: The objective of our study was to compare the health status of the Roma people with that of the general population in Hungary. METHODS: A health examination survey to define the prevalence of metabolic syndrome and its components was performed in a representative random sample (n = 646) of the Roma population aged 20-64 years living in segregated colonies, and data were compared with that obtained in a representative random sample (n = 1819) of the Hungarian population. RESULTS: The risks for central obesity, hypertension and raised triglyceride level among Roma adults were not different from the Hungarian references, while raised fasting plasma glucose or known type 2 diabetes mellitus (OR = 2.65, 95%CI 1.90-3.69), reduced HDL cholesterol level or treated lipid disorder (OR = 2.15, 95%CI 1.65-2.79) were significantly more frequent in all age groups in the Roma sample. The prevalence of metabolic syndrome (OR = 1.37, 95%CI 1.03-1.83) was also significantly higher among Roma than in the general Hungarian population. CONCLUSIONS: Besides tackling the socio-economic determinants of the poor health of Roma people, specific public health interventions considering increased genetic susceptibility to metabolic disturbances are needed to improve their health status.
OBJECTIVES: The objective of our study was to compare the health status of the Roma people with that of the general population in Hungary. METHODS: A health examination survey to define the prevalence of metabolic syndrome and its components was performed in a representative random sample (n = 646) of the Roma population aged 20-64 years living in segregated colonies, and data were compared with that obtained in a representative random sample (n = 1819) of the Hungarian population. RESULTS: The risks for central obesity, hypertension and raised triglyceride level among Roma adults were not different from the Hungarian references, while raised fasting plasma glucose or known type 2 diabetes mellitus (OR = 2.65, 95%CI 1.90-3.69), reduced HDL cholesterol level or treated lipid disorder (OR = 2.15, 95%CI 1.65-2.79) were significantly more frequent in all age groups in the Roma sample. The prevalence of metabolic syndrome (OR = 1.37, 95%CI 1.03-1.83) was also significantly higher among Roma than in the general Hungarian population. CONCLUSIONS: Besides tackling the socio-economic determinants of the poor health of Roma people, specific public health interventions considering increased genetic susceptibility to metabolic disturbances are needed to improve their health status.
Authors: G Enache; E Rusu; A Ilinca; F Rusu; A Costache; M Jinga; C Pănuş; G Radulian Journal: Acta Endocrinol (Buchar) Date: 2018 Jan-Mar Impact factor: 0.877
Authors: János Sándor; Zsigmond Kósa; Klára Boruzs; Julianna Boros; Ildikó Tokaji; Martin McKee; Róza Ádány Journal: Int J Public Health Date: 2017-03-29 Impact factor: 3.380
Authors: Marisa A Nunes; Kristýna Kučerová; Ondřej Lukáč; Milan Kvapil; Jan Brož Journal: Int J Environ Res Public Health Date: 2018-11-21 Impact factor: 3.390
Authors: Jana Petrikova; Martin Janicko; Jan Fedacko; Sylvia Drazilova; Andrea Madarasova Geckova; Maria Marekova; Daniel Pella; Peter Jarcuska Journal: Int J Environ Res Public Health Date: 2018-07-04 Impact factor: 3.390
Authors: János Sándor; Anita Pálinkás; Ferenc Vincze; Nóra Kovács; Valéria Sipos; László Kőrösi; Zsófia Falusi; László Pál; Gergely Fürjes; Magor Papp; Róza Ádány Journal: Int J Environ Res Public Health Date: 2018-08-24 Impact factor: 3.390